期刊文献+

人干扰素α-2b基因植物表达载体的构建及转化 被引量:1

Construction and Transformation of Plant Expression Vector Containing Human Interferon α- 2b Gene
原文传递
导出
摘要 目的:通过构建人干扰素α-2b(hIFNα-2b)基因的植物表达载体,为后期将其导入胡萝卜愈伤组织中作准备。方法:采用PCR技术从人基因组DNA扩增hIFNα-2b编码基因及全长基因,将其克隆于pMD19-T载体中,双酶切hIFNα-2b基因及植物表达载体pBI121,回收目的片段,T4DNA连接酶连接得到植物表达载体pBI121-hIFN。采用三亲交配法将后者导入根瘤农杆菌。结果:经PCR检测,双酶切及DNA序列测定表明hIFNα-2b编码基因及全长基因已分别插入植物表达载体pBI121中,重组表达载体pBI121-IFN已成功转化根瘤农杆菌LBA 4404。结论:成功构建了植物表达载体pBI121-hIFN并转入根瘤农杆菌。 Objective:To construct plant expression vector containing human interferon alpha- 2b (hIFNα -2b) gene, which was to trans- form into carrot callus. Method:The human interferon alpha -2b coding sequence and full -length sequence were amplified from human genomic DNA by PCR, cloned into vector pMD19 -T, hIFN -α-2b genes and plant expression vector pBI121 were degested into pieces, then to recover the target fragments and to construct the new plant expression vector pBI121 -IFN by T4 DNA Ligase, which was trans- formed into Agrobacterium tumefaciens LBA 4404 by Triparental mating method. Result:According to the results of PCR, restriction enzyme digestion and DNA sequencing,it showed that the hIFNα- 2b genes (coding sequence and full -length sequence) were inserted into the plant expression vector pBI121 ,The recombinant expression vector pBI121 - IFN had been successfully transformed into Agrobacterium tu- mefaciens LBA 4404. Conclusion :The plant expression vector pBI121 -IFN was successfully constructed,which brought the possibility for the further use of producing human interferon by transgenic plant.
出处 《生物技术》 CAS CSCD 北大核心 2014年第1期8-12,共5页 Biotechnology
基金 贵州省科学技术基金项目(黔科合J字[2010]2151号)资助
关键词 人干扰素Α-2B 植物双元表达载体 转基因 根瘤农杆菌 Human interferon alpha- 2b Plant binary expression vector Transgene Agrobacterium tumefaciens
  • 相关文献

参考文献2

二级参考文献55

  • 1[1]Fraley RT, Rogers SG, Horsch RB, et al. Expression of bacterial genes in plant cells [J]. Proc Natl Acad Sci USA, 1983, 80(15): 4803-4807.
  • 2[2]Ehsani P, Meunier A, Nato F, et al. Expression of anti human IL-4 and IL-6 scFvs in transgenic tobacco plants [J]. Plant MolBiol, 2003, 52 (1): 17-29.
  • 3[3]Desai UA, Sur G, Dauner TS, et al. Expression and affinity purification of recombinant proteins from plants [J]. Protein Expre Purifi, 2002, 25 (1): 195-202.
  • 4[4]Salmon V, Legrand D, Slomianny MC, et al. Production of human lactoferrin in transgenic tobacco plants [J]. Protein Expr Purif, 1998, 13(1): 127-135.
  • 5[5]Herbers K, Sonnewald U. Production of new/modified proteins in transgenic plants [J]. Curr Opin Biotechnol, 1999, 10(2): 163-168.
  • 6[6]Ma JK, Hiatt A, Hein M, et al. Generation and assembly of secretory antibodies in plants [J]. Science, 1995, 268 (5): 716-719.
  • 7[7]Zubko E, Scutt C, Meyer P. Intrachromosomal recombination between attP regions as a tool to remove selectable marker genes from tobacco transgenes [J]. Nat Biotechnol, 2000, 18(4): 442-445.
  • 8[8]Daniell H, Muthukumar B, Lee SB. Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection [J]. Curr Genet, 2001, 39 (2):109-116.
  • 9[10]Lim AA, Tachibana S, Watanabe Y, et al. Expression and purification of a neuropeptide nocistatin using two related plant viral vectors [J]. Gene, 2002, 289 (1-2): 69-79.
  • 10[11]Dalsgaard K, Uttenthal A, Jones TD, et al. Plant derived vaccine protects target animals agaist a viral disease [J]. Nat Biotechnol, 1997, 15 (3): 248-252.

共引文献20

同被引文献23

  • 1Vidadi Yusibov,Stephen J Streatfielda,Natasha Kushnira. Clinical development of plant - produced recombinant pharmaceuticals: vaccines,antibodies and beyond [ J]. Hum Vaccin, 2011, 7 ( 3 ) : 313 -321.
  • 2Hugh S Mason, Melissa M Herbst - Kralovetz. Plant - derived anti- gens as mucosal vaccines[ J]. Curt Top Microbiol Immunol,2012, 354(354) :101 - 120.
  • 3Kwang - Chul Kwon, Dheeraj Verma, Nameirakpam D Singh, et al. Oral delivery of human biopharmaceuticals, autoantigens and vac- cine antigens bioencapsulated in plant cells [ J ]. Adv Drug Deliv Rev,2013,65(6) : 782 -799.
  • 4Reynald Tremblaya, Hong Diaob, Norm H~iner, et al. The develop- ment of a high - yield recombinant protein bioreactor through RNAi induced knockdown of ATP/ADP transporter in Solanum tuberosum [ J ]. J Biotechnol,2011,156 ( 1 ) : 59 - 66.
  • 5Arseniy E Yuzhalin,Anton G Kutikhin. Interleukin- 12: Clinical usage and molecular markers of cancer susceptibility [ J ]. Growth Factors,2012,30(3) : 176 - 191.
  • 6Lei Yao, Sandra E Pike, Joyce Setsuda, et al. Effective targeting of tumor vaseulature by the angiogenesis inhibitors vasostatin and in- terleukin - 12 [ J ]. Blood,2000,96 (5) : 1900 - 1905.
  • 7Therwa Hamza, John B Barnett, Bingyun Li. Interleukin 12 : a key immunoregulatory cytokine in infection applications [ J ]. Int J Mol Sci,2010,11 (3) :789 -806.
  • 8Yoonkyung Park, Hyeonsook Cheong. Expression and production of recombinant human interleukin - 2 in potato plants [ J ]. Protein Expr Purif,2002,25 ( 1 ) : 160 - 165.
  • 9Richard M. Twyman, Stefan Schillberg, Rainer Fischer. Optimizing the yield of recombinant pharmaceutical proteins in plants [ J ]. Curt Pharm Des ,2013,19 (31) : 5486 - 5494.
  • 10Jia Wei Yang, Jia Xin Fu, Jing Li, et al. A novel co - immunopre- cipitation protocol based on protoplast transient gene expression for studying protein - protein interactions in rice [ J ]. Plant Mol Biol Rep,2014,32( 1 ) : 153 - 161.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部